SARS-Cov-2 and Influenza A/B Combo Test
This NOVAtest ® combo test panel is used to visually detect and differentiate three antigens in human nasal/throat swab specimen, i.e. SARS-COV-2 antigen, Influenza A antigen and Influenza B antigen.
This NOVAtest ® rapid test kit is a combo test panel for the same time detection and differentiation of novel coronavirus (SARS-CoV-2) and influenza A+B antigens in nasopharyngeal swab samples.
The product is designed to be used for population screening in the early phase of diseases outbreaks. Results are for the identification and differentiation of SARS-CoV-2 nucleocapsid, influenza A antigen and influenza B antigen. These antigens are generally detectable in the specimens from upper respiratory tract during the acute phase of infection.
How the Combo Test Helps
Because there are many similar clinical symptoms in the cases of SARS-CoV-2, influenza A, and influenza B, this combo test device can help to reduce the confusion in the diagnosis of these infections, thus proper administration measure can be taken timely to alleviate the symptoms, and proper control measures can be taken to avoid the wide spread of the viruses.
What is SARS-COV-2
Novel coronavirus pneumonia is an infectious disease caused by SARS- CoV-2 infection. SARS-CoV-2 is a novel coronavirus, which was once called COVID-19 when it was first reported in 2019. On February 11, 2020, the International Committee for Taxonomy of Viruses (ICTV) renamed the virus SARS-CoV-2.
So far, there have been seven types of human coronavirus (HCoV) that cause respiratory diseases in humans: HCoV-229E, HCoV-OC43, SARS-CoV, HCoV-NL63, HCoV-HKU1, MERS-CoV and SARS-CoV-2.
The clinical manifestation of systemic symptoms such as fever, fatigue, dry cough, dyspnea, etc., and can rapidly develop severe pneumonia, respiratory failure, acute respiratory distress syndrome, septic shock and multiple organ failure, severe alkali metabolic disorders, etc., and can can be fatal especially when the patient has chronic diseases.